
    
      The aim of this study is to compare the efficacy of EUS-guided CPN versus radiofrequency
      ablation in patients with pain related to pancreatic cancer. By performing a randomized
      controlled trial, the clinical outcomes and cost-effectiveness of this new RFA treatment
      approach can be evaluated.
    
  